Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction (Q44473947)

3 December 2017

Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction (English)

1 reference

3 December 2017

myocardial infarction

1 reference

1 reference

Gerald B Phillips

1

1 reference

PubMed ID

12800107

3 December 2017

Tianyi Jing

series ordinal

2

1 reference

PubMed ID

12800107

3 December 2017

Steven B Heymsfield

series ordinal

3

1 reference

3 December 2017

1 June 2003

1 reference

3 December 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

3 December 2017

52

1 reference

3 December 2017

6

1 reference

3 December 2017

784-790

1 reference

Sex hormones, risk factors and cardiovascular disease

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: the European Fat Distribution Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The association of hypotestosteronemia with coronary artery disease in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Health implications of obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The morphology and metabolism of intraabdominal adipose tissue in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship between regional fat distribution and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Low serum testosterone and sex-hormone-binding-globulin in massively obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Increased Estrogen Production in Obese Men*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship of plasma sex hormones to different parameters of obesity in male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The effect of weight loss on reproductive hormones in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Insulin resistance associated with lower rates of weight gain in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Does central obesity reflect "Cushing's disease of the omentum"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship of serum sex hormones to coronary heart disease .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Sex hormones in male serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship between serum sex hormones and coronary artery disease in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Sex hormones, insulin, lipids, and prevalent ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Effect of obesity and body fat distribution on sex hormones and insulin in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Insulin resistance, body fat distribution, and sex hormones in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Clinical review 26: Insulin resistance in obese and nonobese man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

How good a marker is insulin level for insulin resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Evidence for hyperestrogenemia as the link between diabetes mellitus and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Androgen plasma levels in male diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Testosterone concentrations in women and men with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Pathogenesis of NIDDM. A balanced overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Glucose tolerance and diabetes in chronic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Frequency of Diabetes Mellitus in Patients with Klinefelter's Syndrome of Different Chromosome Constitutions and the XYY Syndrome. Plasma Insulin and Growth Hormone Level After a Glucose Load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Abnormal Insulin Secretion in Myotonic Dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

The effects of metformin and diet on plasma testosterone and leptin levels in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

Effect of testosterone and estradiol in a man with aromatase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900072-6

10.1016/S0026-0495(03)00072-6

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12800107